Literature DB >> 17657832

Serrated neoplasia of the colorectum.

Nathan T Harvey1, Andrew Ruszkiewicz.   

Abstract

Serrated polyps of the colorectum form a group of related lesions which include aberrant crypt foci (ACF), conventional hyperplastic polyps, mixed (admixed) polyps, serrated adenomas and sessile serrated adenomas. In recent years the molecular differences between these morphologically similar lesions have been highlighted, and their differing biological potential has been realised. In particular, the sessile serrated adenoma has become recognised as the precursor lesion to a group of sporadic colorectal carcinomas characterised by morphological and molecular features distinct from conventional adenomas. These recent findings have challenged the long held paradigm that all colorectal carcinomas arise via the traditional adenoma-carcinoma sequence. In addition, they present a major challenge for the early detection and management of colorectal cancer, which is no longer regarded as a homogeneous entity.

Entities:  

Mesh:

Year:  2007        PMID: 17657832      PMCID: PMC4611210          DOI: 10.3748/wjg.v13.i28.3792

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  57 in total

1.  Precancerous lesions of the colon and rectum. Classification and controversial issues.

Authors:  B C MORSON
Journal:  JAMA       Date:  1962-02-03       Impact factor: 56.272

2.  Serrated route to colorectal cancer: back street or super highway?

Authors:  J R Jass
Journal:  J Pathol       Date:  2001-03       Impact factor: 7.996

3.  Immunohistochemical staining patterns of MUC1, MUC2, MUC4, and MUC5AC mucins in hyperplastic polyps, serrated adenomas, and traditional adenomas of the colorectum.

Authors:  A E Biemer-Hüttmann; M D Walsh; M A McGuckin; Y Ajioka; H Watanabe; B A Leggett; J R Jass
Journal:  J Histochem Cytochem       Date:  1999-08       Impact factor: 2.479

4.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 5.  Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia.

Authors:  T A Longacre; C M Fenoglio-Preiser
Journal:  Am J Surg Pathol       Date:  1990-06       Impact factor: 6.394

6.  Concordant CpG island methylation in hyperplastic polyposis.

Authors:  Annie On-On Chan; Jean-Pierre J Issa; Jeffrey S Morris; Stanley R Hamilton; Asif Rashid
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.

Authors:  Shi Yang; Francis A Farraye; Charline Mack; Oksana Posnik; Michael J O'Brien
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

8.  Mixed hyperplastic adenomatous polyps--an underdiagnosed entity. Report of a case of adenocarcinoma arising within a mixed hyperplastic adenomatous polyp.

Authors:  S J Urbanski; A E Kossakowska; N Marcon; W R Bruce
Journal:  Am J Surg Pathol       Date:  1984-07       Impact factor: 6.394

9.  Morphologic reappraisal of serrated colorectal polyps.

Authors:  Emina Torlakovic; Eva Skovlund; Dale C Snover; Goran Torlakovic; Jahn M Nesland
Journal:  Am J Surg Pathol       Date:  2003-01       Impact factor: 6.394

10.  Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.

Authors:  J R Jass; K Baker; I Zlobec; T Higuchi; M Barker; D Buchanan; J Young
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

View more
  10 in total

1.  Prevalence and predictors of interval colorectal cancers in medicare beneficiaries.

Authors:  Gregory S Cooper; Fang Xu; Jill S Barnholtz Sloan; Mark D Schluchter; Siran M Koroukian
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

2.  Undefined familial colorectal cancer.

Authors:  Constantinos Pantelis Zambirinis; George Theodoropoulos; Maria Gazouli
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

3.  Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Margaret T Mandelson; Scott V Adams; Karen J Wernli; Mazyar Shadman; Michelle A Wurscher; Karen W Makar
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

4.  Colorectal cancer: molecular features and clinical opportunities.

Authors:  Daniel L Worthley; Barbara A Leggett
Journal:  Clin Biochem Rev       Date:  2010-05

5.  Sessile serrated adenomas: demographic, endoscopic and pathological characteristics.

Authors:  Suryakanth R Gurudu; Russell I Heigh; Giovanni De Petris; Evelyn G Heigh; Jonathan A Leighton; Shabana F Pasha; Isaac B Malagon; Ananya Das
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

6.  Management of serrated adenomas and hyperplastic polyps.

Authors:  Valerie P Bauer; Harry T Papaconstantinou
Journal:  Clin Colon Rectal Surg       Date:  2008-11

7.  Review of histopathological and molecular prognostic features in colorectal cancer.

Authors:  Ola Marzouk; John Schofield
Journal:  Cancers (Basel)       Date:  2011-06-23       Impact factor: 6.639

8.  The genomics of colorectal cancer: state of the art.

Authors:  Andrew D Beggs; Shirley V Hodgson
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

9.  Predictive and prognostic factors in colorectal cancer: a personalized approach.

Authors:  Myutan Kulendran; John F Stebbing; Christopher G Marks; Timothy A Rockall
Journal:  Cancers (Basel)       Date:  2011-03-29       Impact factor: 6.639

10.  Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers.

Authors:  M D Gill; M G Bramble; M A Hull; S J Mills; E Morris; D M Bradburn; Y Bury; C E Parker; T J W Lee; C J Rees
Journal:  Br J Cancer       Date:  2014-09-23       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.